4D Molecular Therapeutics, Inc.FDMTNASDAQ
LOADING
|||
Price to Sales: Premium Valuation
Trending higher, above historical average, strong compound growth.
Left:
||||
Price-to-sales ratio
Latest
8120.72
↑ 639% above average
Average (7y)
1099.60
Historical baseline
Range
High:8120.72
Low:33.73
CAGR
+86.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 8120.72 | +21127.4% |
| 2023 | 38.26 | -83.3% |
| 2022 | 229.63 | +580.8% |
| 2021 | 33.73 | -58.5% |
| 2020 | 81.25 | -47.1% |
| 2019 | 153.59 | +328.1% |
| 2018 | 35.88 | -65.4% |
| 2017 | 103.77 | - |